Sarepta Therapeutics Inc (SRPT)

Working capital turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue US$ in thousands 1,901,980 1,243,340 933,013 701,887 540,099
Total current assets US$ in thousands 3,073,460 2,579,330 2,557,860 2,604,100 2,485,200
Total current liabilities US$ in thousands 731,684 653,659 619,604 452,733 416,026
Working capital turnover 0.81 0.65 0.48 0.33 0.26

December 31, 2024 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,901,980K ÷ ($3,073,460K – $731,684K)
= 0.81

The working capital turnover for Sarepta Therapeutics Inc has shown a consistent upward trend over the past five years, starting at 0.26 in December 31, 2020, and steadily increasing to 0.81 by December 31, 2024. This indicates that the company is generating more revenue relative to its working capital investment, which suggests improved efficiency in utilizing its working capital to drive sales. The rising trend in working capital turnover signifies that Sarepta Therapeutics Inc is effectively managing its working capital resources to support its business operations and generate revenue.